tiprankstipranks
OptimizeRx’s preliminary Q4 results support bullish thesis, says Roth MKM
PremiumThe FlyOptimizeRx’s preliminary Q4 results support bullish thesis, says Roth MKM
16d ago
OptimizeRx initiated with an Outperform at JMP Securities
PremiumThe Fly
OptimizeRx initiated with an Outperform at JMP Securities
22d ago
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
PremiumPress Releases
OptimizeRx Sets Fourth Quarter 2023 Conference Call for March 28, 2024 at 8:30 a.m. ET
1M ago
OptimizeRx sees 2024 revenue at least $110M, consensus $110.29M
PremiumThe FlyOptimizeRx sees 2024 revenue at least $110M, consensus $110.29M
4M ago
OptimizeRx sees 2023 revenue exceeding $68M-$70M, consensus $68.78M
PremiumThe Fly
OptimizeRx sees 2023 revenue exceeding $68M-$70M, consensus $68.78M
4M ago
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
PremiumPress Releases
OptimizeRx Preannounces Select Expected 2023 Financials and Provides a Business Update
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100